Corient Private Wealth
AMGN icon

Corient Private Wealth’s Amgen AMGN Stock Holding History

Corient Private Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$190M Sell
550,867
-578,511
-51% -$206M 0.27% 70
2025
Q4 		$306M Buy
1,129,378
+780,279
+224% +$248M 0.21% 97
2025
Q3 		$97.1M Sell
349,099
-170,285
-33% -$49.4M 0.15% 143
2025
Q2 		$145M Sell
519,384
-11,477
-2% -$3.25M 0.19% 111
2025
Q1 		$165M Sell
530,861
-33,239
-6% -$9.82M 0.27% 77
2024
Q4 		$146M Sell
564,100
-2,087
-0.4% -$619K 0.24% 96
2024
Q3 		$182M Sell
566,187
-10,419
-2% -$3.41M 0.28% 77
2024
Q2 		$180M Sell
576,606
-299
-0.1% -$87.8K 0.31% 65
2024
Q1 		$164M Sell
576,905
-31,495
-5% -$9.22M 0.29% 78
2023
Q4 		$175M Buy
608,400
+35,217
+6% +$9.6M 0.32% 66
2023
Q3 		$154M Buy
573,183
+7,655
+1% +$1.91M 0.35% 64
2023
Q2 		$126M Buy
565,528
+154,879
+38% +$35.9M 0.29% 81
2023
Q1 		$99.3M Buy
410,649
+214,168
+109% +$52.6M 0.27% 98
2022
Q4 		$51.6M Buy
+196,481
New +$52.7M 0.19% 129

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Corient Private Wealth's AMGN Position: Q1 2026 in Review

Corient Private Wealth reduced its Amgen (AMGN) stake by 51% in Q1 2026, selling an estimated $206M and leaving 550,867 shares worth $190M. The position accounts for 0.27% of the portfolio, ranked #70.

Corient Private Wealth first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $306M in Q4 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Corient Private Wealth held 550,867 shares of Amgen worth $190M as of Q1 2026.
  • Corient Private Wealth sold 578,511 Amgen shares in Q1 2026, an estimated $206M.
  • Amgen made up 0.27% of Corient Private Wealth's portfolio in Q1 2026, its #70 holding.
  • Corient Private Wealth first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Amgen position peaked at $306M in Q4 2025.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.